In This Episode:
Drops September 16
The gut microbiome plays a key role in our overall health and well-being. Researchers are now beginning to understand just how massive a part it plays. One such researcher is Dr. Sabine Hazan. a gastroenterologist and microbiome expert whose work has shown the connection between gut health and disease. She discusses the complexities of gut health and what we can do to manage and optimize health.
Dr. Hazan has published articles in numerous prestigious medical journals, and is the Series Editor on the microbiome for Practical Gastroenterology, a peer-reviewed journal. She is the CEO of Ventura Clinical Trials, where she has 20+ years experience leading clinical trials for cutting-edge research on various medical issues and has done over 300 clinical trials for pharmaceutical companies. She is also the founder & CEO of Progenabiome, a genetic sequencing research laboratory. She leads 35+ studies investigating the role of the gut flora in various diseases. Since March, 2020, Dr. Hazan has been at the forefront of COVID-19 research. Through their study exploring the role of the gut flora in COVID-19, Progenabiome became the first lab worldwide to detect SARS-CoV-2 from patient fecal samples by whole genome sequencing, and the lab that showed a susceptibility marker for COVID in the microbiome.
Dr. Hazan is mastering familial fecal transplant showing hope for kids with Autism. She created The Malibu Microbiome meeting where physicians who perform fecal transplant can discuss their findings freely. She is a coauthor of, Let's Talk Shit: Disease, Digestion and Fecal Transplants.